Swine influenza is an acute, infectious respiratory disease of swine caused mostly by an enveloped type A influenza virus with segmented RNA genome 19 and is characterized by a sudden onset of coughing, dyspnea, fever, and prostration, followed by a rapid recovery. This disease is an enormous economic burden to the swine industry, and concerns are growing on the potential of synergistic infections with swine influenza and porcine reproductive and respiratory syndrome virus. 8, 11, 20 Swine influenza viruses (SIVs) are endemic in most swine-producing regions throughout the world and are responsible for one of the most prevalent respiratory diseases in pigs. Furthermore, maintenance of these viruses in pigs and frequent exchanges of viruses between pigs and other species are facilitated directly by swine operations. 4 Swine influenza viruses of H1N1, H1N2, and H3N2 subtypes have been isolated from pigs in the US and Europe in association with clinical outbreaks. 4, 18, 21 Isolations of H1N1 and H3N2 SIVs from clinical cases have also been documented in Asian countries. 7, 9, 12, 13, 17 In Korea, H1N1 SIV was isolated from clinical samples in 1996 and was designated as A/Swine/Kyunggi/ NVRI-1/96(H1N1). 14 of the H3N2 SIV in Korean swine population. Therefore, this study was undertaken to isolate the H3N2 subtype of SIV from pigs in Korea and to characterize the isolate.
Materials and methods
Clinical sample. In December 1998, an outbreak of acute respiratory disease with an unusually high morbidity was identified in a commercial swine farm (1,200 sows) located in the Kyunggi province of South Korea. Most of the weanling pigs (15-20 kg body weight) in the herd showed mild nasal discharge, sneezing, and open-mouthed jerking or abdominal breathing. The pigs had been routinely vaccinated against atrophic rhinitis and mycoplasmal pneumonia according to the veterinarian's recommendation. Three sick pigs were sacrificed, and lung specimens were collected for routine laboratory examinations. Each lung sample was processed into 10% (w/v) tissue suspension in phosphate buffered saline (pH 7.4). The suspensions were clarified by centrifugation at 1,500 ϫ g for 20 minutes, and the supernatants were ultrafiltered through a 0.2-m syringe filter.
Virus isolation. The Madin-Darby Canine Kidney (MDCK) cells were prepared in minimum essential medium (MEM) supplemented with 5% fetal bovine serum, 20 mM N-2-hydroxythylpiperazine-NЈ-2-ethane-sulfonic acid, 0.2% (w/v) sodium bicarbonate, and antibiotic-antimycotic mixture (100 IU/ml penicillin, 100 mg/ml streptomycin and 0.25 m g/ml amphotericin B). a The prepared cells at 5 ϫ 10 5 cells/ ml were transferred into 24-well cell culture plates, which were then incubated at 37 C under a humid 5% CO 2 atmosphere. After 24-48 hr of incubation, the medium was discarded and cell monolayers were rinsed with serum-free MEM. The cells were adsorbed with 200 l each of lung tissue supernatants. After 1-hr adsorption at 37 C, the inoculum was removed from the wells. One milliliter of MEM containing 2 g/ml L-l-tosylamide-2-phenylethyl chloro- methyl ketone (TPCK)-trypsin b was added to each well. The cells were further incubated at 37 C and observed daily for cytopathic effect (CPE).
Immunofluorescence assay and hemagglutination test. Cells were fixed after 24-36 hr incubation, and a direct immunofluorescence assay was performed to determine the presence of influenza A virus antigen in the cells using a commercial test kit c according to the manufacturer's recommendation. The reagent in the test kit contains purified murine monoclonal antibodies specific to influenza A virus, conjugated to fluorescein isothiocyanate (FITC), diluted in a protein-stabilized buffer solution (pH 7.5). When the cells showed CPE, cell culture fluids were harvested and tested for HA using 0.5% rooster erythrocytes.
Hemagglutination inhibition test. To characterize the isolate, hemagglutination inhibition (HI) test was conducted using reference swine antisera, d each of which was monospecific for H1N1 SIV (A/Sw/IA/1979) or a recent US H3N2 SIV isolate (A/Sw/IA/41305/1998) (NVSL accession number A/Sw/IA/8548-1/98), 21 according to the previously described method. 6 Antiserum to this isolate was of swine origin. The test was performed using the alpha-method (i.e., variable virus concentration and constant antibody titer).
RT-PCR. Briefly, viral RNA was extracted from cell culture supernatants using TRIzol, e a commercially available mixture of guanidium isothiocyanate, according to the manufacturer's instructions. RNA extracts were suspended in 20 l of diethyl pyrocarbonate (DEPC)-treated water. To validate the results of the assay, RNA extracts d of known H1N1 and H3N2 SIVs were used as positive controls for each subtype, and normal cell culture medium served as the negative control. All PCR primers used in this study were designed on the basis of a previous report, 1 and sequences of the primers are summarized in Table 1 . Reverse transcription was performed in a total volume of 25 l. The reaction mixture consisted of 5 l of RNA template, 5 l of Moloney-Murine leukemia virus reverse transcriptase buffer, 10 pmol of primer AHART (forward), 0.3 mM each of diethylnitrophyenyl thiophosphate (dNTP), 20 units of RNasin, and 100 units of M-MLV reverse transcriptase. a The GeneAmp PCR system 2400 f was used at 37 C for 1 hr, after which the temperature was raised to 95 C for 2-3 min to inactivate the reverse transcriptase. Samples were then cooled to 4-5 C by immediately being placed on ice, at which time 25 l of PCR mixture was added to each tube. This mixture consisted of DEPC-treated water, poly-10ϫ PCR reaction buffer, 10 mM each dNTP, 25 mM MgCl 2 , 5 pmol each of AHART forward primer and a subtype-specific reverse primer (AHAH1 or AHAH3), and 1 unit of Taq polymerase. e Thermal cycling began with initial 5-min denaturation at 94 C, followed by 32 cycles at 94 C for 30 sec (denaturation), 55 C for 30 sec (annealing), and 72 C for 1.5 min (extension). The final primer extension was done at 72 C for 7 min. All samples were kept at 4 C until the PCR mixture was analyzed through electrophoresis on 1.5% agarose gel. Polymerase chain reaction products on the gel were visualized through ethidium bromide staining. Apparent size of each PCR product was compared with DNA markers with known sizes. e Samples with PCR products of 325 and 198 base pairs were determined to be H1 and H3 influenza viruses, respectively.
Hemagglutinin gene sequencing. Polymerase chain reaction products were purified using the WIZARD DNA purification kit e and sequenced at the Medicinal Chemistry Research Center, Korean Institute of Science and Technology (Daejeon, South Korea). Hemagglutination activity gene sequences of the isolates were compared with H3 influenza viruses deposited in GenBank.
Results
Influenza A virus was identified in cells incubated with 3 samples using a commercial SIV test kit, and strong positive fluorescence was observed in the cytoplasm of MDCK cells (Fig. 1) . Supernatants of lung tissues from 3 sick pigs agglutinated the rooster red blood cells (RBCs). Hemagglutination activity titers of the samples were 1/256, 1/2,048, and 1/4,096.
In the HI test using monospecific antibody to H1N1 SIV (A/Sw/IA/1979) or a recent US H3N2 SIV isolate (A/Sw/IA/41305/1998), HA activities of the 3 isolates were completely inhibited when reacted with the H3N2 SIV antiserum but not with the H1N1 SIV antiserum, suggesting that the isolates were of the H3N2 subtype. The 3 SIV isolates were designated as A/Sw/ Suwon/107/98, A/Sw/Suwon/108/98, and A/Sw/Suwon/109/98. The isolates were also genetically determined through an RT-PCR assay. All 3 isolates yielded PCR products of 198 base pairs, an indication that these are H3 influenza viruses (Fig. 2) .
In the HA gene sequence comparison of H3 influenza viruses deposited in GenBank, sequence analysis of the PCR products of Korean SIV isolates demonstrated that the isolates shared 96-98% and 95-96% homologies with H3 human influenza viruses and H3 SIVs, respectively (Fig. 3) . These results indicated that HA genes of the isolates were similar to those of known mammalian H3 influenza viruses.
Discussion
Previous serological surveys of SIVs in Korean swine herds showed 7-27% and 15-25% prevalence against H1N1 and H3N2 swine influenza virus infections, respectively. 15 Therefore, it is highly probable that H1N1 or H3N2 SIV could become a significant respiratory pathogen of swine herds in Korea as in other countries. 2, 3, 5 Clinical samples were collected from pigs during an outbreak of acute respiratory disease suspected of having been caused by a virus. Because the index farm had regularly controlled common respiratory diseases through mass vaccination programs (e.g., atrophic rhinitis, pasteurella pneumonia, Haemophilus parasuis, mycoplasmal pneumonia), the owner suspected porcine reproductive and respiratory syndrome virus (PRRSV) infection at that time. A routine laboratory examination of 3 lung samples detected no bacterial agents of respiratory diseases in pigs (e.g., Pasteurella multocida, Actinobacillus pleuropneumoniae). Neither was PRRSV detected through RT-PCR nor antibody titers against PRRSV obtained in pigs of the same age, which suggested the viral pneumonia histologically.
Influenza A virus was identified using a commercial SIV test kit, and the 3 isolates agglutinated rooster RBCs. However, HA protein of SIV is the major viral component showing cross-reactivity among different subtypes. In the HI test using an antibody monospecific to a recent US H3N2 SIV isolate (A/Sw/IA/ 41305/1998), HA activities of the 3 isolates were completely inhibited, which suggested that the isolates were serologically similar to a recent US H3N2 subtype. Virus isolation coupled with immunological reactivity still remains the ''gold'' standard for SIV subtyping.
Hemagglutination activity gene sequence of the Korean SIV isolates in December 1998 indicated that the HA gene of each isolate was quite similar to those of known human H3 influenza viruses. Korean SIV isolates shared 95-97% homologies with Korean human influenza A H3N2 viruses isolated between 1987 and 1999 (GenBank accession numbers AF386604-AF386634) (data not shown). In addition, H3N2 reassortment influenza A viruses isolated from North American pigs in 1998 were similar to the recent human H3 strains. 10, 21 However, further molecular, antigenic, and biological characterizations of Korean H3N2 SIV isolates remain to be carried out.
In conclusion, the respiratory disease of weanling pigs in the index farm was due to influenza A virus of H3N2 subtype, which confirmed that the isolates are similar to a recent US H3N2 SIV isolate. This is the first report of the H3N2 SIV isolated from a clinical case in South Korea. f. Perkin-Elmer Applied Biosystems (PE/ABI), Foster City, CA.
